Long-Term Outcomes with Subcutaneous C1-Inhibitor Replacement Therapy for Prevention of Hereditary Angioedema Attacks: An Open-Label Extension Study of the COMPACT Trial

2018 ◽  
Author(s):  
Timothy Craig ◽  
Bruce Zuraw ◽  
Hilary Longhurst ◽  
Marco Cicardi ◽  
Konrad Bork ◽  
...  
Keyword(s):  
Replacement Therapy ◽  
Hereditary Angioedema ◽  
Extension Study ◽  
C1 Inhibitor ◽  
Long Term Outcomes ◽  
Open Label ◽  
Open Label Extension

scholarly journals Long-Term Outcomes with Subcutaneous C1-Inhibitor Replacement Therapy for Prevention of Hereditary Angioedema Attacks

2019 ◽  
Vol 7 (6) ◽  
pp. 1793-1802.e2 ◽  
Author(s):  
Timothy Craig ◽  
Bruce Zuraw ◽  
Hilary Longhurst ◽  
Marco Cicardi ◽  
Konrad Bork ◽  
...  
Keyword(s):  
Replacement Therapy ◽  
Hereditary Angioedema ◽  
C1 Inhibitor ◽  
Long Term Outcomes

scholarly journals Efficacy of Lanadelumab in Hereditary Angioedema Patients With and Without Prior Long-Term Prophylaxis Use: Interim Results From the HELP Open-Label Extension Study

2020 ◽  
Vol 145 (2) ◽  
pp. AB102
Author(s):  
Kim Paes ◽  
Timothy Craig ◽  
Jonathan Bernstein ◽  
Hilary Longhurst ◽  
Emel Aygoren-Pursun ◽  
...  
Keyword(s):  
Hereditary Angioedema ◽  
Extension Study ◽  
Open Label ◽  
Open Label Extension
Sign in / Sign up

Export Citation Format

Share Document